Evans DG - Search Results

1

Risk reducing mastectomy: outcomes in 10 European centres.

Evans DG, Baildam AD, Anderson E, Brain A, Shenton A, Vasen HF, Eccles D, Lucassen A, Pichert G, Hamed H, Moller P, Maehle L, Morrison PJ, Stoppat-Lyonnet D, Gregory H, Smyth E, Niederacher D, Nestle-Krämling C, Campbell J, Hopwood P, Lalloo F, Howell A. Evans DG, et al. J Med Genet. 2009 Apr;46(4):254-8. doi: 10.1136/jmg.2008.062232. Epub 2008 Nov 7. J Med Genet. 2009. PMID: 18996907

2

A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO.

Evans DG, Eccles DM, Rahman N, Young K, Bulman M, Amir E, Shenton A, Howell A, Lalloo F. Evans DG, et al. J Med Genet. 2004 Jun;41(6):474-80. doi: 10.1136/jmg.2003.017996. J Med Genet. 2004. PMID: 15173236 Free PMC article.

3

Surgical decisions made by 158 women with hereditary breast cancer aged <50 years.

Evans DG, Lalloo F, Hopwood P, Maurice A, Baildam A, Brain A, Barr L, Howell A. Evans DG, et al. Eur J Surg Oncol. 2005 Dec;31(10):1112-8. doi: 10.1016/j.ejso.2005.05.007. Epub 2005 Jul 7. Eur J Surg Oncol. 2005. PMID: 16005602

4

Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening.

Smith A, Moran A, Boyd MC, Bulman M, Shenton A, Smith L, Iddenden R, Woodward ER, Lalloo F, Maher ER, Evans DG. Smith A, et al. Among authors: evans dg. J Med Genet. 2007 Jan;44(1):10-15. doi: 10.1136/jmg.2006.043091. Epub 2006 Nov 1. J Med Genet. 2007. PMID: 17079251 Free PMC article.

5

Probability of BRCA1/2 mutation varies with ovarian histology: results from screening 442 ovarian cancer families.

Evans DG, Young K, Bulman M, Shenton A, Wallace A, Lalloo F. Evans DG, et al. Clin Genet. 2008 Apr;73(4):338-45. doi: 10.1111/j.1399-0004.2008.00974.x. Epub 2008 Feb 26. Clin Genet. 2008. PMID: 18312450

6

Comparison of proactive and usual approaches to offering predictive testing for BRCA1/2 mutations in unaffected relatives.

Evans DG, Binchy A, Shenton A, Hopwood P, Craufurd D. Evans DG, et al. Clin Genet. 2009 Feb;75(2):124-32. doi: 10.1111/j.1399-0004.2008.01146.x. Clin Genet. 2009. PMID: 19215246

7

Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing.

Evans DG, Lalloo F, Cramer A, Jones EA, Knox F, Amir E, Howell A. Evans DG, et al. J Med Genet. 2009 Dec;46(12):811-7. doi: 10.1136/jmg.2009.067850. Epub 2009 Jun 18. J Med Genet. 2009. PMID: 19542080

8

Risk of breast cancer in male BRCA2 carriers.

Evans DG, Susnerwala I, Dawson J, Woodward E, Maher ER, Lalloo F. Evans DG, et al. J Med Genet. 2010 Oct;47(10):710-1. doi: 10.1136/jmg.2009.075176. Epub 2010 Jun 28. J Med Genet. 2010. PMID: 20587410

9

Risk assessment and management of high risk familial breast cancer.

Evans DG, Lalloo F. Evans DG, et al. J Med Genet. 2002 Dec;39(12):865-71. doi: 10.1136/jmg.39.12.865. J Med Genet. 2002. PMID: 12471197 Free PMC article. Review.

10

Sensitivity of BRCA1/2 mutation testing in 466 breast/ovarian cancer families.

Evans DG, Bulman M, Young K, Gokhale D, Lalloo F. Evans DG, et al. J Med Genet. 2003 Sep;40(9):e107. doi: 10.1136/jmg.40.9.e107. J Med Genet. 2003. PMID: 12960223 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,356 results

Search Page

Filters